MINNEAPOLIS, May 26, 2026 (GLOBE NEWSWIRE) — Vireo Growth Inc. (CSE: VREO) (OTCQX: VREOF) (“Vireo” or the “Company”), today announced that its subsidiary, 256 County Route 117 Perth LLC (the “Buyer”), completed the acquisition of premises located at 256 County Route 117 in Perth, NY (the “Property”). The Property, also known as Vireo’s Johnstown, New York facility, is a 389,000 square foot cannabis cultivation and production facility previously leased from IIP-NY 2 LLC (“IIP” or “Seller”), a subsidiary of Innovative Industrial Properties, Inc. Vireo’s acquisition of the Property comes after Vireo exercised its purchase option contained in a lease between Vireo Health of New York, LLC, as tenant, and IIP, as landlord. The purchase price for the Property was US$88.5 million. Pursuant to the terms of a purchase agreement between the...

Acquisition brings Mars heritage for complex planetary missions, as well as precision mechanisms essential for next-generation space infrastructure including orbital data centers and constellationsMotiv’s robotic arm on the Perseverance roverMotiv Space Systems has been acquired by Rocket Lab. Motiv built the robotic arm for the Perseverance rover (pictured), which was the most capable ever deployed on Mars in terms of load capacity, precision, and sensing. Motiv also built the zoom, focus, and filter wheels for the primary imager for the mission.LONG BEACH, Calif., May 26, 2026 (GLOBE NEWSWIRE) — Rocket Lab Corporation (Nasdaq: RKLB), a global leader in launch services and space systems, today announced it has completed the acquisition of Motiv Space Systems (“Motiv”), a California-based company specializing in...

KYIV, Ukraine and NEW YORK, May 26, 2026 (GLOBE NEWSWIRE) — Kyivstar Group Ltd. (Nasdaq: KYIV; KYIVW), the parent company of JSC Kyivstar (“Kyivstar”), Ukraine’s leading digital operator and part of VEON Group (Nasdaq: VEON), today announced it is expanding its energy assets with the acquisition of six solar power plants in the Lviv region. The group of six acquired assets has a total installed capacity of 105 megawatts (MW). The total consideration paid is UAH 3.6 billion (USD 80.8 million). The solar assets being acquired generated approximately 113 GWh of electricity, while delivering approximately UAH 682 million of revenue and UAH 596 million of EBITDA in 20251. This acquisition marks another step forward in the development of Kyivstar’s energy generation portfolio. The company began expanding its energy asset base in...

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree ADVANCED MEDICAL SOLUTIONS GROUP PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date...

Tampa, May 26, 2026 (GLOBE NEWSWIRE) — Advantive, a provider of mission-critical software for specialty manufacturing and distribution businesses, today announced its acquisition of Insequence, a leading provider of automotive sequencing and manufacturing execution system (MES) software headquartered in Smyrna, Tennessee. Automotive manufacturers and suppliers are navigating increasing production complexity, evolving OEM requirements, and ongoing supply chain volatility. In this environment, real-time sequencing accuracy, plant floor visibility, and AI-driven production intelligence have become critical to operational success.  Insequence has been at the forefront of just-in-sequence (JIS) and MES innovation for three decades, enabling automotive suppliers to synchronize production, optimize inventory, and meet stringent delivery...

NEW YORK, May 26, 2026 (GLOBE NEWSWIRE) — All In FutureTech Alliance Inc. (Nasdaq: AGAE) (“AIFA” or the “Company”) today announced that it has filed a Current Report on Form 8-K with the U.S. Securities and Exchange Commission (the “SEC”) relating to the Company’s previously announced transaction to acquire HyalRoute Fiber Optic Group (“HyalRoute”) at a price of US$10.00 per share. As part of the filing, the Company also released supplemental information provided by the transaction seller regarding HyalRoute’s business operations, infrastructure assets, strategic positioning, and projected financial performance. Details of the materials are set forth below: Overview of HyalRoute Group and Financial Outlook HyalRoute Communication Group Limited is a leading fiber-optic network and digital infrastructure company in ASEAN, founded...

New “Muskie Data Campus” establishes one of the largest scalable AI and HPC development sites in Kentucky EASTON, Md., May 26, 2026 (GLOBE NEWSWIRE) — TeraWulf Inc. (Nasdaq: WULF) (“TeraWulf” or the “Company”), which owns and operates vertically integrated, next-generation digital infrastructure, today announced the acquisition of a hyperscale high-performance computing (“HPC”) development site strategically located in Eastern Kentucky (the “Muskie Data Campus”). The acquisition meaningfully expands TeraWulf’s portfolio of large-scale, energy-advantaged digital infrastructure campuses and advances the Company’s strategy of developing shovel-ready AI and HPC sites with long-term power availability, robust transmission infrastructure, and strong community alignment. The Muskie Data Campus, acquired from Industrial Equity Partners...

On 2 January 2026, Schouw & Co. initiated a share buy-back programme as outlined in Company Announcement no. 59 of 18 December 2025. Under the programme, Schouw & Co. will acquire shares for up to DKK 240 million during the period 2 January to 31 December 2026. The buy-back will be structured in accordance with Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (MAR) and the Commission’s delegated regulation (EU) 2016/1052 of 8 March 2016 (“Safe Harbour” rules).Trading day No. of shares Average price Amount DKK    Accumulated until 15 May 2026 131,283 667.28 87,603,049    Monday, 18 May 2026 1,000 676.50 676,500    Tuesday, 19 May 2026 1,000 675.50 675,500    Wednesday, 20 May 2026 1,000 669.00 669,000    Thursday, 21 May 2026 1,000 684.00 684,000    Friday,...

Acquisition expected to deepen Global-e’s standard logistics capabilities and improve the post-purchase experience for merchants and shoppersAcquisition focuses on asset-light carrier capabilities and offering of competitive best in class cross-border, domestic and “last mile delivery” standard logistics, supporting sophisticated solutions such as direct injection, consolidated returns and customs brokerageWill enable expansion of global offering to merchant segments that require a Non-Merchant of Record solution, leveraging the existing Passport platformPETAH-TIKVA, Israel, May 26, 2026 (GLOBE NEWSWIRE) — Global-e Online Ltd. (NASDAQ: GLBE) (“Global-e” or the “Company”), the platform powering global direct-to-consumer e-commerce, today announced that it has entered into a definitive agreement (the “Agreement”) to acquire...

Curevo’s lead asset, amezosvatein, is a Phase 3-ready shingles vaccine with potential to increase vaccination rates by delivering improved tolerability versus approved products SEATTLE, May 26, 2026 (GLOBE NEWSWIRE) — Curevo Vaccine (Curevo), a clinical-stage biotechnology company dedicated to developing varicella zoster virus (VZV) vaccines with improved tolerability, today announced entry into a definitive agreement to be acquired by Lilly. Curevo’s lead product candidate is amezosvatein, an adjuvanted subunit vaccine for the prevention of shingles in adults. While the current standard of care for shingles prevention is effective, tolerability challenges can limit the overall vaccination rates and contribute to second-dose hesitancy, leaving a meaningful portion of patients with reduced or no protection against shingles and its...